Cargando…

Hospital readmissions for patients with prostate cancer are higher after radiotherapy than after prostatectomy

PURPOSE: To compare hospital readmissions, biochemical recurrence rates, incidence of metastasis, and cancer-specific and overall mortality for prostate cancer patients undergoing radiotherapy vs. radical prostatectomy. The secondary outcome was to identify patient and disease characteristics affect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kesavan, Arshvin, Vickneson, Keeran, Esuvaranathan, Kesavan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756149/ https://www.ncbi.nlm.nih.gov/pubmed/34983121 http://dx.doi.org/10.4111/icu.20210313

Ejemplares similares

SGLT2-inhibitors; more than just glycosuria and diuresis
por: Fathi, Amir, et al.
Publicado: (2020)

UBC®Rapid Is Sensitive in Detecting High-Grade Bladder Urothelial Carcinoma and Carcinoma in situ in Asian Population
por: Zang, Zhijiang, et al.
Publicado: (2023)

Bacillus Calmette-Guérin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survival
por: Rahmat, Juwita N., et al.
Publicado: (2018)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021)

Tumor and Microenvironment Modification during Progression of Murine Orthotopic Bladder Cancer
por: Tham, Sin Mun, et al.
Publicado: (2011)

Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy
por: Vogel, Marco M. E., et al.
Publicado: (2019)

Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN α Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model
por: Tham, Sin Mun, et al.
Publicado: (2021)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
por: Oehus, Ann-Kathrin, et al.
Publicado: (2020)

Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy
por: Zedan, Ahmed H., et al.
Publicado: (2018)

Embryonal Rhabdomyosarcoma of the Adult Urinary Bladder: A Rare Case Report of Misclassification as Inflammatory Myofibroblastic Tumor
por: Chen, Kelven Weijing, et al.
Publicado: (2015)

Stereotactic Radiotherapy after Radical Prostatectomy in Patients with Prostate Cancer in the Adjuvant or Salvage Setting: A Systematic Review
por: Schröder, Christina, et al.
Publicado: (2022)

Adjuvant radiotherapy after prostatectomy for prostate cancer in Japan: a multi-institutional survey study of the JROSG
por: Aoki, Manabu, et al.
Publicado: (2014)

Use of high and very high dose radiotherapy after radical prostatectomy for prostate cancer in the United States
por: Alexidis, P., et al.
Publicado: (2018)

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
por: Viani, Gustavo Arruda, et al.
Publicado: (2019)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

A pilot clinical study of developing an External Assist Targeting Device for rapid and precise renal calyx access during percutaneous nephrolithotomy
por: Wu, Qinghui, et al.
Publicado: (2023)

Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
por: Kim, Myong, et al.
Publicado: (2018)

Trends in prostatectomy utilization: Increasing upfront prostatectomy and postprostatectomy radiotherapy for high‐risk prostate cancer
por: Kaps, Bryan, et al.
Publicado: (2020)

Functional recovery after radical prostatectomy for prostate cancer
por: Ko, Young Hwii
Publicado: (2018)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
por: Barra, Salvina, et al.
Publicado: (2018)

Robotic Radical Prostatectomy in Patients with Previous Prostate Surgery and Radiotherapy
por: Acar, Ömer, et al.
Publicado: (2014)

Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy
por: Kim, Dong Soo, et al.
Publicado: (2015)

Comparison of Oncological Outcomes Between Radical Prostatectomy and Radiotherapy by Type of Radiotherapy in Elderly Prostate Cancer Patients
por: Guo, Xiao-Xiao, et al.
Publicado: (2021)

Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy
por: Ang, Wei Xia, et al.
Publicado: (2016)

Outcomes of prostate cancer patients after robot-assisted radical prostatectomy compared with open radical prostatectomy in Korea
por: Jung, Jaehun, et al.
Publicado: (2023)

Recurrence of Prostate Cancer with Cutaneous Metastasis after Radical Prostatectomy
por: Patel, Parth, et al.
Publicado: (2015)

Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer
por: von Hardenberg, Jost, et al.
Publicado: (2021)

Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy
por: Tseng, Chi-Shin, et al.
Publicado: (2021)

The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6—A Study on 320 Patients After Radical Prostatectomy
por: Dolejsova, Olga, et al.
Publicado: (2018)

The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study
por: Eisemann, Nora, et al.
Publicado: (2015)

Postoperative Radiotherapy after Radical Prostatectomy: Indications and Open Questions
por: Ghadjar, Pirus, et al.
Publicado: (2012)

Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
por: Kwon, Ohseong, et al.
Publicado: (2014)

Early or delayed radiotherapy after prostatectomy—who really benefits?
por: van der Poel, Henk, et al.
Publicado: (2017)

State of the art paper: Cardiac computed tomography of the left atrium in atrial fibrillation
por: Bodagh, Neil, et al.
Publicado: (2023)

The accumulation of metabolic syndrome components is associated with higher risk of positive surgical margin among patients with localized prostate cancer after radical prostatectomy
por: Zheng, Xiaonan, et al.
Publicado: (2019)

Wirelessly Activated Nanotherapeutics for In Vivo Programmable Photodynamic‐Chemotherapy of Orthotopic Bladder Cancer
por: Sun, Bowen, et al.
Publicado: (2022)

Adding radiotherapy to androgen deprivation therapy in men with node-positive prostate cancer after radical prostatectomy: A meta-analysis
por: Guo, Lijuan, et al.
Publicado: (2020)

PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions
por: le Guevelou, Jennifer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mhg9sk02tr99vnn6c90k5sgg89